LifeMD, Inc. (LFMDP)
USD 22.12
(1.28%)
USD 22.12
(1.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.48 Million USD | 63.49% |
| 2022 | -39.68 Million USD | 26.91% |
| 2021 | -54.3 Million USD | 6.09% |
| 2020 | -57.81 Million USD | -1900.94% |
| 2019 | -2.88 Million USD | -40.54% |
| 2018 | -2.05 Million USD | -92.61% |
| 2017 | -1.06 Million USD | 9.12% |
| 2016 | -1.17 Million USD | -347.98% |
| 2015 | -262.21 Thousand USD | 50.61% |
| 2014 | -530.87 Thousand USD | 2.84% |
| 2013 | -546.4 Thousand USD | -1.18% |
| 2012 | -540.02 Thousand USD | 6.31% |
| 2011 | -576.36 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -6.17 Million USD | -184.19% |
| 2024 Q2 | -6.3 Million USD | -2.18% |
| 2023 Q1 | -2.85 Million USD | 58.4% |
| 2023 Q3 | -4.56 Million USD | 6.66% |
| 2023 Q4 | -2.17 Million USD | 52.48% |
| 2023 FY | -14.48 Million USD | 63.49% |
| 2023 Q2 | -4.89 Million USD | -71.6% |
| 2022 FY | -39.68 Million USD | 26.91% |
| 2022 Q1 | -13.1 Million USD | 4.08% |
| 2022 Q2 | -12.9 Million USD | 1.55% |
| 2022 Q3 | -6.81 Million USD | 47.17% |
| 2022 Q4 | -6.85 Million USD | -0.58% |
| 2021 Q4 | -13.66 Million USD | -8.52% |
| 2021 Q1 | -11.91 Million USD | 63.13% |
| 2021 Q2 | -16.12 Million USD | -35.31% |
| 2021 Q3 | -12.59 Million USD | 21.92% |
| 2021 FY | -54.3 Million USD | 6.09% |
| 2020 Q4 | -32.32 Million USD | -57.45% |
| 2020 Q1 | -1.74 Million USD | -235.12% |
| 2020 Q2 | -3.21 Million USD | -84.91% |
| 2020 Q3 | -20.53 Million USD | -537.98% |
| 2020 FY | -57.81 Million USD | -1900.94% |
| 2019 Q3 | -973.7 Thousand USD | -16.87% |
| 2019 Q4 | -519.36 Thousand USD | 46.66% |
| 2019 FY | -2.88 Million USD | -40.54% |
| 2019 Q2 | -833.16 Thousand USD | -47.89% |
| 2019 Q1 | -563.36 Thousand USD | 23.94% |
| 2018 Q1 | -279.31 Thousand USD | -44.35% |
| 2018 FY | -2.05 Million USD | -92.61% |
| 2018 Q4 | -740.7 Thousand USD | -68.87% |
| 2018 Q3 | -438.63 Thousand USD | 26.59% |
| 2018 Q2 | -597.49 Thousand USD | -113.91% |
| 2017 Q1 | -374.98 Thousand USD | 47.05% |
| 2017 Q2 | -225.47 Thousand USD | 39.87% |
| 2017 Q4 | -193.5 Thousand USD | 29.27% |
| 2017 FY | -1.06 Million USD | 9.12% |
| 2017 Q3 | -273.56 Thousand USD | -21.33% |
| 2016 Q1 | -105.09 Thousand USD | 61.19% |
| 2016 FY | -1.17 Million USD | -347.98% |
| 2016 Q3 | -207.7 Thousand USD | -35.2% |
| 2016 Q2 | -153.63 Thousand USD | -46.18% |
| 2016 Q4 | -708.25 Thousand USD | -240.99% |
| 2015 FY | -262.21 Thousand USD | 50.61% |
| 2015 Q4 | -270.82 Thousand USD | -1609.51% |
| 2015 Q3 | 17.94 Thousand USD | 204.49% |
| 2015 Q2 | -17.17 Thousand USD | -319.17% |
| 2015 Q1 | 7834.00 USD | 105.41% |
| 2014 Q1 | -177.63 Thousand USD | 38.06% |
| 2014 Q4 | -144.91 Thousand USD | -9.01% |
| 2014 Q3 | -132.94 Thousand USD | -76.37% |
| 2014 Q2 | -75.37 Thousand USD | 57.57% |
| 2014 FY | -530.87 Thousand USD | 2.84% |
| 2013 Q3 | -168.66 Thousand USD | -736.89% |
| 2013 Q2 | -20.15 Thousand USD | 71.53% |
| 2013 Q1 | -70.78 Thousand USD | 43.3% |
| 2013 Q4 | -286.8 Thousand USD | -70.04% |
| 2013 FY | -546.4 Thousand USD | -1.18% |
| 2012 FY | -540.02 Thousand USD | 6.31% |
| 2012 Q1 | -35.82 Thousand USD | 0.0% |
| 2012 Q2 | -215.69 Thousand USD | -502.07% |
| 2012 Q3 | -163.64 Thousand USD | 24.13% |
| 2012 Q4 | -124.85 Thousand USD | 23.7% |
| 2011 FY | -576.36 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -13.47 Million USD | -7.507% |
| BIMI International Medical Inc. | -15.33 Million USD | 5.536% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -309.931% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 2598.151% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 3461.78% |
| Leafly Holdings, Inc. | -7.05 Million USD | -105.492% |
| Leafly Holdings, Inc. | -7.05 Million USD | -105.492% |
| LifeMD, Inc. | -14.48 Million USD | -0.0% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | -99.483% |
| PetMed Express, Inc. | -8.16 Million USD | -77.521% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 99.897% |